Oxycodone/dextromethorphan - Endo
Alternative Names: EN-3229; OxycoDexLatest Information Update: 12 Sep 2018
At a glance
- Originator Endo Pharmaceuticals
- Class Morphinans; Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action NMDA receptor antagonists; Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 11 Jul 2006 No development reported - Phase-II for Pain in USA (PO)
- 06 Aug 2002 Phase-II clinical trials in Pain in USA (PO)